Antibiotic Resistance Plans Expand, but Patients Still Face Testing Gaps, WHO Warns
By Babajide Moronfolu | Babacares | November 21, 2026
When a bacterial infection needs antibiotics, a lab test can help clinicians choose a medicine that will work. Yet access to that testing remains limited in many countries, even as more governments adopt plans to combat antimicrobial resistance, the World Health Organization reported on November 16. who.int
More countries have plans. Few have fully put them into practice.
WHO’s 2026 survey found that 173 countries reported having national plans to tackle antimicrobial resistance, up from 79 in 2017. Yet only 22% of surveyed countries reported that they had fully implemented their plans and had the funding needed to carry them out. who.int
The scale of the problem was already clear in earlier surveillance. WHO estimates that about 1 in 6 lab-confirmed bacterial infections covered by its global surveillance in 2023 showed resistance to antibiotics. Resistance develops in bacteria, reducing the effectiveness of medicines used to treat the infections they cause. who.int
Why testing matters for patients
Testing can help identify what is causing an infection and which antibiotics are likely to work. With limited access to testing, patients are more likely to receive an antibiotic they do not need or one that is ineffective against their infection. WHO says closing the gap will require investment in laboratory testing, infection prevention and access to essential medicines. who.int
Read more on Babacares.com, subscribe and share.


Comments